Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Kazunori, Noguchi"'
Autor:
Shigeo Shimose, Atsushi Hiraoka, Masatoshi Tanaka, Hideki Iwamoto, Takaaki Tanaka, Kazunori Noguchi, Hajime Aino, Taizo Yamaguchi, Satoshi Itano, Hideya Suga, Takashi Niizeki, Etsuko Moriyama, Tomotake Shirono, Yu Noda, Naoki Kamachi, Shusuke Okamura, Masahito Nakano, Takumi Kawaguchi, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract This study aimed to investigate the clinical characteristics of patients with unresectable hepatocellular carcinoma (HCC), who were eligible for sequential systemic therapy. We evaluated 365 patients with HCC who underwent systemic therapy a
Externí odkaz:
https://doaj.org/article/a8c7a028541d4aafa780bbde3d8cc0b9
Autor:
Shigeo Shimose, Atsushi Hiraoka, Masahito Nakano, Hideki Iwamoto, Masatoshi Tanaka, Takaaki Tanaka, Kazunori Noguchi, Hajime Aino, Kei Ogata, Masahiko Kajiwara, Satoshi Itano, Yoshinori Yokokura, Taizo Yamaguchi, Hiroshi Kawano, Norito Matsukuma, Hideya Suga, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Shusuke Okamura, Takumi Kawaguchi, Hironori Koga, Takuji Torimura
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8530-8541 (2021)
Abstract Background and Aims Sequential therapy with molecular‐targeted agents (MTAs) is considered effective for unresectable hepatocellular carcinoma (HCC) patients. This study purposed to evaluate the efficacy of sequential therapy with sorafeni
Externí odkaz:
https://doaj.org/article/0894e9642c0c4631b38c4aa5d3985b9c
Autor:
Tomoya Sano, Keisuke Amano, Tatsuya Ide, Keiji Yokoyama, Kazunori Noguchi, Hiroki Nakamura, Hiroshi Isoda, Miki Ohno, Miki Shirachi, Yasuyo Morita, Yoichi Yano, Shuji Sumie, Toshihiro Kawaguchi, Reiichiro Kuwahara, Teruko Arinaga‐Hino, Hirokazu Takahashi, Satoshi Shakado, Fumihito Hirai, Takumi Kawaguchi
Publikováno v:
Hepatology Research. 53:26-34
The real-world efficacy of sofosbuvir/velpatasvir treatment for patients with hepatitis C virus-related decompensated cirrhosis is unclear. We aimed to identify factors that improve liver functional reserve after treatment.This was a multicenter retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84543c6528049c23690085ea91e2190f
https://doi.org/10.1111/hepr.13837
https://doi.org/10.1111/hepr.13837
Autor:
Masahiko Kajiwara, Hironori Koga, Takumi Kawaguchi, Taizo Yamaguchi, Hideya Suga, Yu Noda, Shusuke Okamura, Masatoshi Tanaka, Atsushi Hiraoka, Takaaki Tanaka, Takuji Torimura, Tomotake Shirono, Naoki Kamachi, Hiroshi Kawano, Masahito Nakano, Takashi Niizeki, Satoshi Itano, Shigeo Shimose, Kazunori Noguchi, Yoshinori Yokokura, Hajime Aino, Kei Ogata, Hideki Iwamoto, Norito Matsukuma
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8530-8541 (2021)
Cancer Medicine
Cancer Medicine
Background and Aims Sequential therapy with molecular‐targeted agents (MTAs) is considered effective for unresectable hepatocellular carcinoma (HCC) patients. This study purposed to evaluate the efficacy of sequential therapy with sorafenib (SORA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69fca81c2c710227e89f771d0cd26df5
https://doi.org/10.1002/cam4.4367
https://doi.org/10.1002/cam4.4367
Autor:
Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, Kunihide Ishii, Masaru Morita, Yasuyo Morita, Gen Sugiyama, Hirofumi Fukushima, Yoichi Yano, Kazunori Noguchi, Hiroki Nakamura, Junjiro Hisatomi, Hiroto Kumemura, Miki Shirachi, Shinji Iwane, Michiaki Okada, Yuichi Honma, Teruko Arinaga-Hino, Ichiro Miyajima, Kei Ogata, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Ryoko Kuromatsu, Takuji Torimura, DAAs Multicenter Study Group
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163884 (2016)
The aim of this study was to evaluate the efficacy of daclatasvir plus asunaprevir therapy in patients infected with hepatitis C virus and determine its relevance to resistant variants.A total of 629 consecutive patients infected with hepatitis C vir
Externí odkaz:
https://doaj.org/article/43826e91e146470a8ed457a5bb2b9989
Autor:
Shunji Koya, Takumi Kawaguchi, Hiroo Matuse, Kazunori Noguchi, Naoki Kamachi, Keisuke Hirota, Masahito Nakano, Takashi Niizeki, Takuji Torimura, Hideki Iwamoto, Ryuki Hashida, Hironori Koga, Shigeo Shimose, Tomotake Shirono
Publikováno v:
Molecular and Clinical Oncology
Severe ascites is an adverse event of ramucirumab (RAM), a second-line treatment for hepatocellular carcinoma (HCC). Ascites can be associated with various factors, including nutritional status and muscle quality. The aim of the present study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b90bcab59308a099614813a81f0618
http://europepmc.org/articles/PMC7947949
http://europepmc.org/articles/PMC7947949
Autor:
Hideki, Iwamoto, Takashi, Niizeki, Hiroaki, Nagamatsu, Kazuomi, Ueshima, Takako, Nomura, Teiji, Kuzuya, Kazuhiro, Kasai, Yohei, Kooka, Atsushi, Hiraoka, Rie, Sugimoto, Takehiro, Yonezawa, Akio, Ishihara, Akihiro, Deguchi, Hirotaka, Arai, Shigeo, Shimose, Tomotake, Shirono, Masahito, Nakano, Shusuke, Okamura, Yu, Noda, Naoki, Kamachi, Miwa, Sakai, Hiroyuki, Suzuki, Hajime, Aino, Norito, Matsukuma, Satoru, Matsugaki, Kei, Ogata, Yoichi, Yano, Takato, Ueno, Masahiko, Kajiwara, Satoshi, Itano, Kunitaka, Fukuizumi, Hiroshi, Kawano, Kazunori, Noguchi, Masatoshi, Tanaka, Taizo, Yamaguchi, Ryoko, Kuromatsu, Atsushi, Kawaguchi, Hironori, Koga, Takuji, Torimura, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan
Publikováno v:
Cancers
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
BACKROUND: Not all patients with hepatocellular carcinoma (HCC) benefit from treatment with molecular targeted agents such as sorafenib. We investigated whether New-FP (fine-powder cisplatin and 5-fluorouracil), a hepatic arterial infusion chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f1483325e31a608b20b62e39c0d540
https://pubmed.ncbi.nlm.nih.gov/33562793
https://pubmed.ncbi.nlm.nih.gov/33562793
Autor:
Kazunori Noguchi, Shusuke Okamura, Yoshinori Yokokura, Taizo Yamaguchi, Hideki Iwamoto, Miki Ono, Hideya Suga, Ken Miyazaki, Takuji Torimura, Takumi Kawaguchi, Tomotake Shirono, Shigeo Shimose, Masahito Nakano, Takashi Niizeki, Hironori Koga, Masatoshi Tanaka
Publikováno v:
Nutrients
Volume 12
Issue 4
Nutrients, Vol 12, Iss 1076, p 1076 (2020)
Volume 12
Issue 4
Nutrients, Vol 12, Iss 1076, p 1076 (2020)
We aimed to investigate the impact of the controlling nutritional status (CONUT) score, an immuno-nutritional biomarker, on the prognosis of patients with hepatocellular carcinoma (HCC) treated with lenvatinib (LEN). This retrospective study enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88f3784ccee2a5d77e52807096509f4f
Autor:
KAZUNORI NOGUCHI1, KOHEI TANAKA2
Publikováno v:
Theory & Applications of Categories. 2016, Vol. 31 Issue 1, p1-30. 30p.
Autor:
Kazunori Noguchi, Naoki Kamachi, Ryoko Kuromatsu, Taizo Yamaguchi, Tomotake Shirono, Masahito Nakano, Takumi Kawaguchi, Hironori Koga, Takashi Niizeki, Takuji Torimura, Shigeo Shimose, Yu Noda, Hideki Iwamoto, Shusuke Okamura, Masatoshi Tanaka, Hideya Suga
Publikováno v:
Cancers, Vol 13, Iss 160, p 160 (2021)
Cancers
Volume 13
Issue 1
Cancers
Volume 13
Issue 1
We aimed to evaluate the impact of alternating lenvatinib (LEN) and trans-arterial therapy (AT) in patients with intermediate-stage hepatocellular carcinoma (HCC) after propensity score matching (PSM). This retrospective study enrolled 113 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f39cef31ffa4d2ad6cfad066196ff0e
https://doi.org/10.3390/cancers13010160
https://doi.org/10.3390/cancers13010160